The Meandering Pathway Leading from Genotyping to Personalized Management of LQTS
Long QT Syndrome has been the first inherited arrhythmogenic syndrome to be extensively characterized in clinical cardiology: its genetic bases were disclosed in the early nineties by Mark Keating thus opening the field of molecular arrhythmology1-3. The publication of Keating's work generated a lot of excitement among those involved in the care of LQTS patients as it became clear that the possibility to identify in the clinics the DNA variants that cause LQTS would impact clinical management of families affected by the disease. (SELECT FULL TEXT TO CONTINUE)
- Received March 21, 2012.
- Accepted March 22, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited